CN Patent

CN101001613B — 作为液体制剂载体的多孔片剂

Assigned to Veloxis Pharmaceuticals AS · Expires 2010-09-29 · 16y expired

What this patent protects

可以以便利、灵活和可再现方式加载相对高量的药物上可接受的液体制剂的新片剂产品，例如，所述的液体制剂携带治疗、预防和/或诊断活性物质。可以以大规模批量生产这种新型的适于承载的片剂产品并且贮存至使用为止，且每批或次批均可以载有相同或不同的药物上可接受的液体制剂和/或活性物质。本发明的适于承载的片剂具有30％v/v或30％v/v以上的孔隙率。本发明还提供了加载了这类液体制剂的片剂及其制备方法。

USPTO Abstract

可以以便利、灵活和可再现方式加载相对高量的药物上可接受的液体制剂的新片剂产品，例如，所述的液体制剂携带治疗、预防和/或诊断活性物质。可以以大规模批量生产这种新型的适于承载的片剂产品并且贮存至使用为止，且每批或次批均可以载有相同或不同的药物上可接受的液体制剂和/或活性物质。本发明的适于承载的片剂具有30％v/v或30％v/v以上的孔隙率。本发明还提供了加载了这类液体制剂的片剂及其制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101001613B
Jurisdiction
CN
Classification
—
Expires
2010-09-29
Drug substance claim
No
Drug product claim
No
Assignee
Veloxis Pharmaceuticals AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.